Metraipolis › archive › dc_c76c16e4ece3

Ionizable guanidine-based lipid nanoparticle for targeted mRNA delivery and cancer immunotherapy — Europe PMC PMID:41134881

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41134881
DOI
10.1126/sciadv.adx5970
License (as archived)
solo-consultazione
Archived
2026-11-09T02:27:53.950Z
SHA-256 of the archived text
403d5c05f2c6b850fcb2448d8dc1195e8b6918f9853920941ff791864979bea6
Stable URL of this page
https://metraipolis.com/documento/dc_c76c16e4ece3

How to cite

Ionizable guanidine-based lipid nanoparticle for targeted mRNA delivery and cancer immunotherapy — Europe PMC PMID:41134881 — Europe PMC (en), https://europepmc.org/article/MED/41134881 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c76c16e4ece3 (Metraipolis archive dc_c76c16e4ece3, sha256 403d5c05f2c6b850fcb2448d8dc1195e8b6918f9853920941ff791864979bea6)
BibTeX
@misc{dcc76c16e4ece3,
  title = {Ionizable guanidine-based lipid nanoparticle for targeted mRNA delivery and cancer immunotherapy — Europe PMC PMID:41134881},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41134881},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c76c16e4ece3; sha256 403d5c05f2c6b850fcb2448d8dc1195e8b6918f9853920941ff791864979bea6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41134881. Agents can read the archived copy with the MCP tool read_document.